Back

Benefits of sotagliflozin across the full range of baseline blood pressure in the SOLOIST-WHF Trial

30 August 2026 (16:15 - 17:00)
Organised by: Logo
Congress Presentation Part of: Heart failure frontiers: from decongestion to advanced therapeutics Pharmacotherapy ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Edan Zitelny

Mount Sinai Fuster Heart Hospital, New York City (United States of America)

7 More presentations in this session

Presentation thumbnail
Natriuretic peptide receptor 1 targeting chimeras for cardiovascular selective degradation of extracellular proteins
Doctor K. Zhang (Wuhan, CN)
Abstract Slides Video
Presentation thumbnail
Multicenter machine learning based risk assessment model, integrating omics, clinical and patient centred data to prevent recurrent heart failure events
Professor J. Comin-Colet (Barcelona, ES)
Abstract Slides Video
Presentation thumbnail
Preemptive cardiorenal phenotyping to forecast diuretic resistance in acute heart failure: derivation and internal validation of the strides score
Doctor H. Al Farhan (Baghdad, IQ)
Presentation thumbnail
Pre-event guideline-directed optimized medical therapy intensity and in-hospital mortality in heart failure–related cardiogenic shock: insights from the ALT-SHOCK registry
Doctor G. Guarnieri (Milan, IT)
Abstract Slides Video
Presentation thumbnail
The ACETAZ-HF trial: intravenous furosemide plus oral acetazolamide for rapid decongestion in acute HFrEF and sustained outpatient benefit
Doctor R. Rascon Sabido (Veracruz, MX)
Abstract Slides Video

Access the full session

Session thumbnail
Heart failure frontiers: from decongestion to advanced therapeutics

The Event

Event poster

ESC Congress 2026

30 August 2026 16:15 CET
You may be interested in
thumbnail
Congress Session
Pharmacotherapy
23 May 2023
thumbnail
Congress Presentation
Mediators of the benefit of sotagliflozin in patients with worsening heart failure in SOLOIST-WHF
26 August 2023
thumbnail
Congress Presentation
Clinical efficacy of sotagliflozin for heart failure outcomes across cardiac biomarker levels in SCORED
10 May 2026
thumbnail
Congress Presentation
Efficacy of sotagliflozin among older adults: a pooled analysis of SCORED and SOLOIST-WHF
30 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources